PlushCare Cost Explained: What Drives the Monthly GLP-1 Price

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This guide is part of the PlexusDx Education Hub, where we break down GLP-1 therapies, weight-management protocols, and the genetic factors that quietly shape cost and outcome alike. Browse all Peptides & GLP-1 education

What follows is independent editorial analysis. PlexusDx holds no commercial relationship with PlushCare or its parent company, and nothing here involves affiliate links or paid placement.

Cost is the first question most people bring to a telehealth GLP-1 program, and PlushCare is one of many services competing for that decision. This review unpacks how the pricing is put together — the fees, the medication line, and the levers that move your total — rather than handing you a single number. Written for balance, not as a purchase recommendation. Figures reflect the landscape as of April 2026.

How PlushCare structures its costs

PlushCare (operating under Accolade) runs on a subscription telehealth model, which means your spend is rarely a single charge. It typically separates into a membership or visit component that covers clinical access and a medication component that covers whatever the pharmacy dispenses. The company publishes its current numbers on PlushCare's official website, and because those numbers move, the site is the only reliable source for today's figure.

What actually drives your monthly total

Three variables do most of the work. First, the compound: semaglutide and tirzepatide sit at different price points. Second, the dispensing pathway — an FDA-approved brand product routed to a retail pharmacy prices differently than a compounded version from a 503A pharmacy. Third, the subscription tier and how follow-up visits are bundled. Across the telehealth GLP-1 market as of April 2026, total monthly outlay generally lands somewhere between roughly $200 and $700-plus, with genuinely wide variance depending on those three choices.

Why the medication line moves the most

Of the three levers, the compound itself usually swings the bill hardest. Dose escalation over the first months, product form, and whether you're on a brand or compounded formulation all feed into it — which is why two members of the same program can pay very different amounts.

Cash-pay versus insurance in this model

Most compounded GLP-1 telehealth runs cash-pay, and PlushCare's weight program should be read through that lens: verify on the brand's own site whether any portion touches insurance, because coverage for compounded products is limited and inconsistent. Cash-pay pricing has the advantage of transparency — what you see is generally what you pay — but it also means the sticker isn't offset by a plan.

Where compounded and brand pricing diverge

The single biggest fork in the cost road is compounded versus branded. Programs dispensing branded semaglutide or tirzepatide carry the manufacturer's price; programs using 503A-compounded versions price independently. Neither is automatically the better deal — availability, dosing, and clinical fit all matter, and the right comparison is total value rather than the lowest line item.

The cost variable no invoice itemizes: your genetics

Every pricing sheet leaves out the one input that shapes whether the spend pays off: your own metabolic biology. Variants in FTO (fat-mass and obesity-associated), GLP1R (the receptor every GLP-1 compound targets), MC4R (a satiety and energy-balance receptor), and TCF7L2 (tied to glucose handling and GLP-1 secretion) describe the terrain any compound acts on. These are pathway-level markers — they don't predict what any specific drug will do, but they frame the biology a clinician prescribes into.

Before committing to a monthly protocol, the Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights, including those FTO, MC4R, and TCF7L2 markers that shape baseline appetite and energy-balance biology. That's the test before you invest logic — spend on information before spending month after month on a protocol. The genetic test is $298, and it never predicts response to any specific medication.

Not affiliated: PlexusDx has no affiliation or commercial relationship with PlushCare or any company discussed in this article.

How PlexusDx prices its own protocols

For transparency, PlexusDx offers its own Weight Management Protocols on flat monthly pricing: Semaglutide Injection at $189/month, Tirzepatide Injection at $289/month, and a microdose option at $129/month flat, alongside Semaglutide Oral and Tirzepatide Oral. All are 503A-compounded. The differentiator isn't only the number — it's pairing the protocol with upstream genetic context.

Related reading on PlexusDx: GLP 1 Drugs, GLP 1 Hormone, What Is GLP 1, GLP 1 What Is.

Disclaimer: This article is educational. PlexusDx is not affiliated with PlushCare and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols — this review compares approaches in the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Compare approaches: see the PlexusDx Weight Management Protocols, or start upstream and take the Precision Peptide Genetic Test to understand your GLP-1 pathway before you commit to a monthly bill.

Frequently Asked Questions

Why doesn't PlushCare list one flat price?

Because the total is assembled from parts. A membership or visit fee covers clinical access, and a separate medication charge depends on the compound, dose, and whether it is brand or 503A-compounded. Add subscription tier on top, and the final monthly figure varies widely from one member to the next.

Is compounded GLP-1 always cheaper than brand?

Not necessarily. Compounded 503A products price independently of the manufacturer, so they are sometimes lower, but availability, dose, and clinical fit all factor in. The honest comparison weighs total value and appropriateness rather than assuming the lowest line item is the best choice.

Does insurance reduce the cost here?

Most compounded GLP-1 telehealth operates cash-pay, and coverage for compounded products is limited and inconsistent. Check PlushCare's own site for any insurance interaction before assuming a plan will offset the price. Cash-pay does at least bring the benefit of clearer, upfront numbers.

How does knowing my genetics affect cost?

It doesn't lower the invoice, but it can inform whether a monthly protocol fits your biology before you start paying for it. The Precision Peptide Genetic Test maps pathway-level variants like FTO so your provider has context — the test-before-you-invest idea applied to a recurring expense.

This guide is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.